FDA approves pill with sensor that digitally tracks if patients have ...
Abilify MyCite (aripiprazole tablets with sensor) has an ingestible sensor embedded in the pill that records that the medication was taken. The product is approved for the treatment of...
Otsuka And Proteus® Announce The First U.S. FDA Approval of A …
ABILIFY MYCITE (aripiprazole tablets with sensor) is a drug-device combination product comprised of Otsuka’s oral aripiprazole tablets embedded with an Ingestible Event Marker (IEM) sensor.
ABILIFY MYCITE- aripiprazole tablet with sensor - DailyMed
Jan 31, 2025 · A MYCITE Patch (wearable sensor) is designed to detect the ingestion of the ABILIFY MYCITE tablets with sensor, record the ingestion of the IEM, and transmit ingestion data to the mobile patient application (app).
How does Abilify MyCite work? - Drugs.com
Jan 24, 2025 · The oral tablet formulation Abilify MyCite (aripiprazole) is embedded with the ingestible Proteus sensor that allows patients, and, if given access, doctors and caregivers, to track ingestion of the Abilify medication on a smartphone or web-based portal.
Abilify MyCite Starter Kit (oral with sensor) - Drugs.com
Aug 7, 2024 · The oral tablet formulation Abilify MyCite (aripiprazole) is embedded with the ingestible Proteus sensor that allows patients, and, if given access, doctors and caregivers, to track ingestion of the Abilify medication on a smartphone or web-based portal.
FDA Approves First Digital Pill That Can Track Whether You've …
Nov 14, 2017 · Abilify MyCite is an antipsychotic with an ingestible sensor that transmits data to a patch, which then sends the information to a smartphone app. The Food and Drug Administration has approved...
FDA Approves First 'Digital' Pill: How Does It Work?
Nov 16, 2017 · The actual drug is Abilify (generic name aripiprazole), a medication used to treat schizophrenia and bipolar disorder. The drug is sold by Otsuka Pharmaceutical, and the sensor in the pill was...
ABILIFY MYCITE (aripiprazole tablets with sensor)
These highlights do not include all the information needed to use ABILIFY MYCITE safely and effectively. See full prescribing information for ABILIFY MYCITE. See full prescribing …
Aripiprazole tablets with sensor (Abilify Mycite®) FDA approved November 2017 . Indication: Aripiprazole tablets with an Ingestible Event Marker (IEM) sensor is indicated for the treatment of adults with schizophrenia, bipolar I disorder, or as an adjunctive treatment of patients with major depressive disorder (MDD)
FDA Approves First Drug with Ingestible Digital Adherence Sensor
Nov 14, 2017 · Aripiprazole tablets with sensor (Abilify MyCite) is approved to treat schizophrenia, manic and mixed episodes for patients with bipolar I disorder, and as an add-on for depression treatment. The FDA has approved the first drug with a digital ingestion tracking system, according to a press release.
- Some results have been removed